MedTrace Logo

Vasopressin Use in Septic Shock From Türkiye

NCT06953297 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2025-05-01

No results posted yet for this study

Summary

The goal of this observational study is to examine the early hemodynamic effects and clinical outcomes of vasopressin use in patients with septic shock. The study aims to compare adult ICU patients who received norepinephrine alone versus those who received vasopressin in addition to norepinephrine.

The main question it aims to answer is:

Does adding vasopressin to norepinephrine improve blood pressure, lactate levels, and survival in patients with septic shock?

Researchers used retrospective medical records of patients treated between January and December 2024. Data such as blood pressure, heart rate, lactate levels, and mortality were collected and analyzed to assess treatment response and outcomes.

Conditions

  • Septic Shock
  • Vasodilatory Shock
  • Critical Illness Sepsis, Severe
  • Critical Illness
  • Intensive Care Medicine
  • Vasopressor Therapy

Sponsors & Collaborators

  • Karadeniz Technical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-15
Completion
2025-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06953297 on ClinicalTrials.gov